Cargando…
Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK
Hereditary transthyretin-mediated amyloidosis (hATTR) is challenging to diagnose early owing to the heterogeneity of clinical presentation, which differs according to the TTR gene variant and its penetrance in each individual. The TTR variants seen most frequently in the UK and Ireland (T80A, V142I...
Autores principales: | Gillmore, Julian D., Reilly, Mary M., Coats, Caroline J., Cooper, Rob, Cox, Helen, Coyne, Mark R. E., Green, Andrew J., McGowan, Ruth, Moody, William E., Hawkins, Philip N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122857/ https://www.ncbi.nlm.nih.gov/pubmed/35419651 http://dx.doi.org/10.1007/s12325-022-02139-9 |
Ejemplares similares
-
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2020) -
Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015) -
Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015) -
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
por: Brito, Dulce, et al.
Publicado: (2023) -
The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)